Cenna Biosciences
Pre-clinicalCenna's proprietary small peptides and molecules revolutionize Alzheimer's treatment by inhibiting beta amyloid production. Learn more on our treatment of AD.
Founded
2018
Focus
Small Molecules
About
Cenna's proprietary small peptides and molecules revolutionize Alzheimer's treatment by inhibiting beta amyloid production. Learn more on our treatment of AD.
Funding History
1Total raised: $26M
Series A$26MCormorant Asset ManagementMar 15, 2022
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile